Home » Medical Devices » Pulmonary Drug Delivery Devices Market

Pulmonary Drug Delivery Devices Market By Technology (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Copd, Cystic Fibrosis, Diabetes) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Summary
Table Of Content

Market Insights

The report titled “Pulmonary Drug Delivery Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall pulmonary drug delivery devices market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on the type of technology, application, and different geographies. Pulmonary drug delivery devices have been used for decades to deliver drugs for the treatment of respiratory diseases.

The pulmonary drug delivery pathway is considered the most efficient mode of drug delivery in respiratory diseases because the lungs provide a huge surface area of alveoli with a vast capillary network, which provides an excellent absorbing surface for the administration of drugs. Over the decade, rapid onset of action and higher efficiency were observed as the key driving factors for pulmonary delivery systems and also symptomatic relief in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Developments in device technology have also led to the development of more proficient delivery systems capable of providing large doses and microparticles into the lung.

For the purpose of this study, the global pulmonary drug delivery devices market is segmented on the basis of technology type into dry powder inhalers, metered dose inhalers, and nebulizers. Furthermore, dry powder inhalers are sub segmented into unit-dose devices and multi-dose devices. Metered-dose inhalers are of two types: manually actuated pressurized inhalers and breath-actuated pressurized inhalers. Nebulizers comprise jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Market size estimates and forecasts for these segments for the period 2015–2025 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2017–2025, considering 2016 as the base year.

The global pulmonary drug delivery devices market is also segmented on the basis of types of applications such as asthma, COPD, cystic fibrosis, diabetes, and others (allergic rhinitis, tuberculosis, among others). Market size estimates and forecasts for these segments for the period 2015–2025 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2017–2025, considering 2016 as the base year.

The geographical segmentation of the pulmonary drug delivery devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. The market size and forecast for these segments during 2015–2025 and their CAGRs for the period 2017–2025 are provided in this report.

The pulmonary drug delivery devices market is observed as the most diversified and competitive market, comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck & Co., Inc., Novartis AG, Omron Corporation, and Sunovion Pharmaceuticals Inc., among others.

Based on the type of technology, the global pulmonary drug delivery devices market is segmented as follows:

Dry powder inhalers

Unit-dose inhalers
Multi-dose inhalers

Metered-dose inhalers

Manually-actuated, pressurized inhaler
Breath-actuated, pressurized inhaler

Nebulizers

Jet nebulizers
Ultrasonic wave nebulizers
Vibrating mesh nebulizers

Metered dose inhalers accounted for the largest market share in the pulmonary drug devices market in 2016 due to key drivers such as the rising prevalence of asthma and COPD around the world, high patient convenience, and the fact that the products and technology have penetrated the market and been observed as the most preferred technology by physicians over these years. During the forecast period of 2017–2025, dry powder inhalers were anticipated as the fastest-growing segment due to key driving factors such as short administration and preparation times, fewer irritant effects, control of the inhaled dose, and API protection. A few major brands available in the dry powder inhalers category are Spiriva, Atrovent, Foradil, Rotahaler, and FlowCaps, among others.

Based on the type of application, the global pulmonary drug delivery devices market is segmented as follows:

Asthma
COPD
Cystic fibrosis
Diabetes
Others (allergic rhinitis, tuberculosis, among others)

Asthma was identified as the most important application segment in the pulmonary drug delivery devices market in 2016 due to key driving factors such as a user-friendly designed device, the most efficient and convenient method of drug delivery in asthma, and the rising prevalence of asthma, which is fueling the overall growth of pulmonary drug delivery devices. Diabetes was observed as the fastest-growing segment due to ongoing research and development for pulmonary delivery of insulin, a few product approvals delivering insulin through the pulmonary pathway, high patient convenience due to non-invasive drug delivery, and the rising prevalence of diabetes globally.

For this study, the global market for pulmonary drug delivery devices is divided into:

North America
Europe
Asia Pacific
Latin America (LATAM)
Middle East and Africa (MEA)

In the base year 2016, North America accounted for the largest market share due to key driving factors such as the rising prevalence of asthma and COPD, high public awareness related to early diagnosis and treatment for respiratory disorders, developed healthcare infrastructure, and high accessibility to products with advanced technology. According to the Centers for Disease Control and Prevention (CDC), in 2015, 18.4 million adults had asthma, of which 6.2 million were children. During the forecast period of 2017–2025, Asia Pacific was observed as the fastest-growing region due to key drivers such as the rising prevalence of asthma and COPD, increasing air pollution due to rapid industrial growth, and high public awareness related to respiratory disease diagnosis. According to a report published by the United Nations (UN), globally, around seven million people a year die prematurely due to indoor and outdoor pollution, with about 70 percent of those deaths occurring in the Asia Pacific.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Pulmonary Drug Delivery Devices Market Portraiture
2.1.1. Global Pulmonary Drug Delivery Devices Market, by Technology, 2016
2.1.2. Global Pulmonary Drug Delivery Devices Market, by Application, 2016
2.1.3. Global Pulmonary Drug Delivery Devices Market, by Geography, 2016

Chapter 3. Pulmonary Drug Delivery Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Respiratory Diseases: Epidemiology
3.3. Brand Analysis & Comparison: Pulmonary Drug Delivery Devices
3.4. Pipeline Introduction: Pulmonary Drug Delivery Devices
3.5. Drivers
3.6. Challenges
3.7. Opportunities
3.8. Porter’s Five Forces Analysis
3.9. Attractive Investment Proposition, by Geography
3.10. Major Agreements, Partnerships and Collaborations
3.11. Competitive Landscape
3.11.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Technology
4.3. Dry Powder Inhalers
4.3.1. Single-dose inhalers
4.3.2. Multi-dose inhalers
4.4. Metered Dose Inhalers
4.4.1. Manually-actuated pressurized inhaler
4.4.2. Breath-actuated pressurized inhaler
4.5. Nebulizers
4.5.1. Jet nebulizers
4.5.2. Ultrasonic wave nebulizers
4.5.3. Vibrating mesh nebulizers

Chapter 5. Global Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Application
5.2. Asthma
5.3. COPD
5.4. Cystic fibrosis
5.5. Diabetes
5.6. Others (allergic rhinitis, tuberculosis, among others)

Chapter 6. Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.2.1. North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.2.2. North America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.3.1. Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.3.2. Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Spain
6.3.3.5. Italy
6.3.3.6. Rest of Europe
6.4. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.5.1. Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.6.1. MEA Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.6.2. MEA Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA Pulmonary Drug Delivery Devices Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. UAE
6.6.3.2. Saudi Arabia
6.6.3.3. South Africa
6.6.3.4. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Novartis AG
7.3. GlaxoSmithKline plc
7.4. AstraZeneca plc
7.5. Teva Pharmaceutical Industries Ltd.
7.6. Merck & Co., Inc.
7.7. MannKind Corporation
7.8. F. Hoffmann-La Roche Ltd.
7.9. Bristol-Myers Squibb Company
7.10. Mylan N.V.
7.11. Omron Corporation
7.12. 3M Healthcare
7.13. Sunovion Pharmaceuticals, Inc.
7.14. Koninklijke Philips N.V.
7.15. Gerresheimer AG
7.16. Bespak
7.17. AptarGroup, Inc.
7.18. SHL Group
7.19. Nypro Healthcare Inc.
7.20. Chiesi Farmaceutici S.p.A.
7.21. Hovione

List of Figures

FIG. 1 Pulmonary Drug Delivery Devices: Market Segmentation
FIG. 2 Global Pulmonary Drug Delivery Devices Market Share, by Technology, 2016 (Value %)
FIG. 3 Global Pulmonary Drug Delivery Devices Market, by Application, 2016 (US$ Mn)
FIG. 4 Global Pulmonary Drug Delivery Devices Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Unit-Dose Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Multi-Dose Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Manually-Actuated Pressurized Inhaler Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Breath-Actuated Pressurized Inhaler Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Jet Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Ultrasonic Wave Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Vibrating Mesh Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Asthma Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 15 Global COPD Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 16 Global Cystic Fibrosis Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 17 Global Diabetes Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 18 Global Other Diseases Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 19 U.S. Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 20 Canada Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 21 U.K. Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 22 Germany Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 23 France Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 24 Spain Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 25 Italy Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 26 Rest of Europe Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 27 Japan Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 28 China Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 29 India Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 30 Rest of Asia Pacific Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 31 Brazil Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 32 Mexico Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 33 Rest of Latin America Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 34 UAE Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 35 Saudi Arabia Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 36 South Africa Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 2 Global Dry Powder Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Metered Dose Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global Nebulizers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 Global Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 North America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 22 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 AstraZeneca plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 MannKind Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Mylan N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Omron Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 3M Healthcare : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Sunovion Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Koninklijke Philips N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Gerresheimer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Bespak: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 AptarGroup, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 SHL Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Nypro Healthcare Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 Chiesi Farmaceutici S.p.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 42 Hovione: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions

What is the size of Pulmonary Drug Delivery Devices Market?

The market for Pulmonary Drug Delivery Devices Market is expected to reach USD 218.6 Bn By 2025.

What is the Pulmonary Drug Delivery Devices Market CAGR?

The Pulmonary Drug Delivery Devices Market is expected to see significant CAGR growth over the coming years, at 5.4%.

What is the Forecast period considered for Pulmonary Drug Delivery Devices Market?

The report is forecasted from 2017-2025.

What is the base year considered for Pulmonary Drug Delivery Devices Market?

The base year of this report is 2016.

Who are the major players in this market?

GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck & Co., Inc., Novartis AG, Omron Corporation, and Sunovion Pharmaceuticals Inc are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –